Navigation Links
Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy for IBS Symptoms
Date:3/23/2009

and support for Bifantis continues to grow

Bifidobacterium infantis 35624, discovered in the early 1990s by microbiologists at Alimentary Health in Cork, Ireland in partnership with P&G, has been independently tested and evaluated in several clinical trials conducted with humans. This latest review provides continued clinical evidence of Bifantis efficacy in helping to manage a range of gastrointestinal issues including abdominal pain, bloating, constipation, diarrhea, gas and urgency. Bifantis efficacy data has been published or referenced in several medical journals, including the American Journal of Gastroenterology(2), Gastroenterology(3), New England Journal of Medicine(4), Public Library of Science (PLoS)(5) and Nutrition in Clinical Practice(6). Bifantis is found in the number one gastroenterologist recommended probiotic supplement in the United States(7).

Susan Abeln, Principal Scientist at Procter & Gamble, said, "P&G has worked with Alimentary Health to study and develop a supplement with Bifantis because we firmly believe in the benefits of this strain for the millions of Americans struggling to manage digestive upsets each day. We're excited to make Bifantis available to consumers nationwide this spring."

Further credentialing the probiotic strain, P&G recently announced that Bifantis meets the probiotic guidelines established by The International Scientific Association for Probiotics and Prebiotics (ISAPP). These guidelines include five key criteria that consumers should consider when selecting a probiotic product -- strain specificity, clinical proof, packaging, and the quality and quantity of probiotics in a product. Bifantis is proven to fully meet these guidelines, making it a good option for those who want to build and maintain a natural defense against abdominal discomfort and episodic digestive upsets such as constipation, diarrhea, urgency, gas and
'/>"/>

SOURCE Procter & Gamble
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
3. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
4. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
5. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
6. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
7. InstaCare Corp. Reviewing M&A Plans
8. CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path
9. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
10. Multicountry review shows that Bug Buster Kits reduce head lice and social stigma
11. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... can mark one more item off her bucket list: skydiving. ... community is the oldest woman to have flown at an indoor ... she exclaimed. “I’ve always wanted to jump from an airplane ... would be ok.” , “We put on nylon coveralls, helmets, and ... “I don’t remember it being noisy, but the wind was blowing ...
(Date:5/29/2015)... Red Hot & Blue Restaurants , Inc. ... Blue restaurant at 525 New Waverly Place in Cary, North ... Red Hot & Blue Restaurant was previously located in this ... moved to a new location in the center,” said McCann. ... the activities on the Promenade–with outdoor seating and service, next ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... unit have reached a confidential Risperdal lawsuit ( ... allegedly developed gynecomastia due to his use of ... case had been selected for the third bellwether ... a mass tort litigation underway in Pennsylvania’s Philadelphia ...
(Date:5/29/2015)... World Patent Marketing, a vertically integrated ... has signed a 10 year licensing agreement for Live ... let people learn about any topic and get answers ... is an exciting day for World Patent Marketing and ... CEO and Creative Director of World Patent Marketing, "This ...
(Date:5/29/2015)... May 29, 2015 The print component ... a circulation of approximately 250,000 and an estimated readership ... a vast social media strategy, and across a network ... the digital version of the campaign, click here. ... print publication. Inside, the actress, model and producer details ...
Breaking Medicine News(10 mins):Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5
... News) -- Breast cancer patients with low levels of vitamin ... study finds. Experts say the new findings support what ... that vitamin D is related to breast health in some ... Laurie Kirstein, a breast surgeon at Beth Israel Medical Center ...
... PHILADELPHIA Black cardiac arrest victims are more likely to ... large black population than when they,re brought to hospitals with ... from the University of Pennsylvania School of Medicine. The study ... Heart Journal . The Penn team found that, among ...
... in cardiac development has been newly associated with congenital ... ventricular outflow tract. These are the findings from a ... the journal Birth Defects Research Part A . ... valve stenosis, coarctation of the aorta, hypoplastic left heart ...
... Proton radiography imaging used prior to and during proton ... treatment delivery and a lower dose of radiation compared ... to a study presented today at the Cancer Imaging ... co-sponsored by the American Society for Radiation Oncology (ASTRO) ...
... models, produced by combining a patient,s CT scans and ... 3D printing technology is a fast and ... Radiologists are able to transform ultra high-resolution CT patient ... printer commonly used in architecture, engineering and construction. An ...
... Flu vaccination is safe for kidney transplant patients and lowers ... says. Kidney transplant patients face a high risk of ... studies have suggested that flu vaccines could trigger an immune ... the study authors noted. In addition, some research has ...
Cached Medicine News:Health News:Low Vitamin D Levels Linked to More Aggressive Breast Cancers 2Health News:Low Vitamin D Levels Linked to More Aggressive Breast Cancers 3Health News:Black cardiac arrest patients more likely to be admitted to hospitals with lowest survival rates 2Health News:Study identifies second gene associated with specific congenital heart defects 2Health News:Proton imaging provides more accuracy, less radiation to pediatric cancer patients 2Health News:Flu Vaccine Appears Safe After Kidney Transplant 2
(Date:5/29/2015)... MENLO PARK, Calif. , May 29, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, presented additional ... Cancer Research (AACR) Advances in Brain Cancer Research ... product candidate VAL-083 (dianhydrogalactitol) to treat ...
(Date:5/29/2015)... NEW YORK , May 29, 2015  World-renowned prostate ... evaluates new findings on the benefit of MR/Ultrasound Fusion-Guided ... "Our Prostate Cancer Center at Lenox ... MR/Ultrasound Fusion Biopsy System in New York City ... high and low risk prostate cancers. The use of an ...
(Date:5/28/2015)... and HOUSTON , May 28, 2015 ... EPI) today reported financial results for the second quarter and ... specified otherwise, are expressed in Canadian dollars and in accordance ... Results ESSA recorded a net loss of ... ended March 31, 2015 (Q2-2015), compared to a net loss ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... WASHINGTON, Sept. 12 The following is a,statement ... FDA Advisory Committee meeting underscores the many,considerations that ... anemia,treatment in patients suffering from chronic kidney disease. ... practicing,nephrologists, and other members of the medical community ...
... Corporation (Nasdaq: ROCM ) announced today ... study which further demonstrates the,effectiveness of the ... newly released September issue of the "Annals ... double-blind, controlled clinical trial,involving 212 adult patients ...
Cached Medicine Technology:Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients 2Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial 2Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: